Study of Immunotherapy in Autoantibody Positive Psychosis

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

December 31, 2017

Conditions
SchizophreniaPsychosisAuto Immune Disorders
Interventions
BIOLOGICAL

Plasma Exchange

PLEX is a procedure in which the subject's blood is passed through a medical device which separates out plasma from the other blood components, and replaces the plasma with albumin or plasma or other colloid. PLEX therefore removes circulating pathogenic antibodies, and furthermore therapeutic benefit after PLEX supports an antibody mediated pathogenesis of disease. In PLEX, 200-250 mL plasma per kg body weight is exchanged typically over 7-14 days using 5% albumin as replacement, often at alternate days which increases the amount of immunoglobulin removed due to equilibrium effects. PLEX modality (centrifugation or filtration), type of anticoagulation, and dose scheduling will be determined by local centre practice.

BIOLOGICAL

Intravenous immunoglobulin

"Active Comparator: Intravenous Immunoglobulin (IVIG) IVIG is a pooled blood product from 3000-100,000 human blood donors with direct immunomodulatory effects.~IVIG will be given at a dose of 2g/kg over 4 days. Dosing at 2g/kg is established in neurological disorders, with limited evidence that lower doses are less effective although adequate dosing studies have not been performed."

Trial Locations (5)

Unknown

University Hospitals Birmingham, Birmingham

Cambridge University Hospitals, Cambridge

Nottingham University Hospitals, Nottingham

Oxford University Hospitals, Oxford

University Hospitals Southampton, Southampton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Oxford

OTHER

collaborator

Stanley Medical Research Institute

OTHER

collaborator

McPin Foundation

OTHER

lead

University of Cambridge

OTHER